Metraipolis › archive › dc_c01006797f48

Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance — Europe PMC PMID:41514589

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41514589
DOI
10.3390/cancers18010076
License (as archived)
solo-consultazione
Archived
2026-11-07T10:23:44.263Z
SHA-256 of the archived text
a824a30bbdc6ba9539c00cb3da1cb78b52e2dbaa49cfa9db6fca74131dbffd20
Stable URL of this page
https://metraipolis.com/documento/dc_c01006797f48

How to cite

Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance — Europe PMC PMID:41514589 — Europe PMC (en), https://europepmc.org/article/MED/41514589 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c01006797f48 (Metraipolis archive dc_c01006797f48, sha256 a824a30bbdc6ba9539c00cb3da1cb78b52e2dbaa49cfa9db6fca74131dbffd20)
BibTeX
@misc{dcc01006797f48,
  title = {Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance — Europe PMC PMID:41514589},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41514589},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c01006797f48; sha256 a824a30bbdc6ba9539c00cb3da1cb78b52e2dbaa49cfa9db6fca74131dbffd20},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514589. Agents can read the archived copy with the MCP tool read_document.